West Pharmaceutical Services Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones

2025.12.01 22:06

I'm PortAI, I can summarize articles.

West Pharmaceutical Services Inc. stock fell 1.12% to $274.14 on Monday, underperforming compared to competitors. The S&P 500 and Dow Jones also declined. West Pharmaceutical is 21.43% below its 52-week high. Competitors Abbott Laboratories and Becton Dickinson & Co. also fell, while Baxter International Inc. rose. Trading volume was below average.

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of West Pharmaceutical Services Inc. (WST) slid 1.12% to $274.14 Monday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index falling 0.53% to 6,812.63 and Dow Jones Industrial Average falling 0.90% to 47,289.33. West Pharmaceutical Services Inc. closed 21.43% short of its 52-week high of $348.90, which the company achieved on January 28th. The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Abbott Laboratories (ABT) fell 0.69% to $128.01, Becton Dickinson & Co. (BDX) fell 1.13% to $191.82, and Baxter International Inc. (BAX) rose 1.81% to $19.08. Trading volume (474,829) remained 234,088 below its 50-day average volume of 708,917. Data source: Dow Jones Market Data, FactSet. Data compiled December 1, 2025. This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. (END) Dow Jones Newswires 12-01-25 1706ET